Active ingredient
Asfotase Alfa
4 finished FDA listings contain Asfotase Alfa as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ASFOTASE ALFA
- Dosage forms
- Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 18 mg/.45ml · 28 mg/.7ml · 40 mg/ml · 80 mg/.8ml
- Brand names in FDA listings
- Strensiq
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1720259
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 125513 | ALEXION PHARM | 2015-10-23 | 4 |
Official labeling on DailyMed
- STRENSIQ (ASFOTASE ALFA) SOLUTION [ALEXION PHARMACEUTICALS, INC.] · version 18 · 2025-12-16
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.